UBE2C expression was analyzed in astrocytic tumors, and authors concluded that GB exhibits high levels of this protein compared with low-grade astrocytomas, indicating a correlation between UBE2C expression and glioma tumor grade. Here, UBE2C is linked to central nervous system cancer.